Dynavax

Cartoon of business people competing in a tug of war
Biotech

VC firm fights to end Dynavax's 'empire-building' strategy

Deep Track decried Dynavax's “empire-building exercise” of pursuing external assets, urging the biotech to instead focus on its approved hep B vaccine.
Darren Incorvaia Feb 19, 2025 2:22pm
vials vaccine research vaccines factory manufacturing

Dynavax drops Tdap vaccine after mulling ph. 1 data, competition

Nov 8, 2024 9:31am
cancer cell surrounded by killer T cells

Novel cancer vaccines look beyond T cells to better fight tumors

May 27, 2022 2:00pm